Concepedia

Author

Glykeria Tzatzagou

Aristotle University of Thessaloniki

Also Known As

G Tzatzagou, G. Tzatzagou, GLYKERIA TZATZAGOU, Glykeria Tzatzagou

27

Publications

2.6K

Citations

10

H-Index

5

Concepts

All Affiliations

Aristotle University of ThessalonikiPapageorgiou General HospitalOspedale Sacro Cuore Don CalabriaAzienda Socio Sanitaria Territoriale degli Spedali Civili di BresciaUniversity of Patras
GT

About

Glykeria Tzatzagou is an author at Aristotle University of Thessaloniki specializing in diabetes, clinical trials, and outcomes research.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

1

1

1.7K

2

Diabetes

1

1

1.7K

3

Clinical Trials

1

1

1.7K

4

Cardiovascular Disease

1

1

1.7K

5

Outcomes Research

1

1

1.7K

Glykeria Tzatzagou

×

8

Publications

2.4K

Citations

8

H-Index

YearCitations

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

Adrian F. Hernandez, Jennifer B. Green, Salim Janmohamed,

The Lancet

2018

1.7K

Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial

Evdoxia Kyriazopoulou, Haralampos Milionis, Symeon Metallidis,

Nature Medicine

2021

518

Dapagliflozin decreases ambulatory central blood pressure and pulse wave velocity in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled clinical trial

Eirini Papadopoulou, Charalampos Loutradis, Glykeria Tzatzagou,

Journal of Hypertension

2020

63

Development and validation of SCOPE score: A clinical score to predict COVID-19 pneumonia progression to severe respiratory failure

Evangelos J. Giamarellos‐Bourboulis, Aline de Nooijer, Haralampos Milionis,

Cell Reports Medicine

2022

37

Efficacy and safety of early soluble urokinase plasminogen receptor plasma-guided anakinra treatment of COVID-19 pneumonia: a subgroup analysis of the SAVE-MORE randomised trial

Karolina Akinosoglou, Antigone Kotsaki, Maria Ioanna Gounaridi,

EClinicalMedicine

2022

22

Interferon gamma-induced protein 10 (IP-10) for the early prognosis of the risk for severe respiratory failure and death in COVID-19 pneumonia

Charilaos Samaras, Evdoxia Kyriazopoulou, Eran Reiner,

Cytokine

2022

17

Transitions of blood immune endotypes and improved outcome by anakinra in COVID-19 pneumonia: an analysis of the SAVE-MORE randomized controlled trial

Evdoxia Kyriazopoulou, Yehudit Hasin-Brumshtein, Uros Midic,

Critical Care

2024

16

Dapagliflozin Does Not Affect Short-Term Blood Pressure Variability in Patients With Type 2 Diabetes Mellitus

Eirini Papadopoulou, Marieta Theodorakopoulou, Charalampos Loutradis,

American Journal of Hypertension

2020

11

Page 1